Overview

Effects of Crestor on Inflammation of Atherosclerotic Plaques

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The primary aim of this study is to investigate the effect of 40 mg dose of rosuvastatin on carotid plaque inflammation measured with MRI and PET scanning, to evaluate whether these techniques are promising for future proof of principle studies. A number of patients will receive placebo as a control.
Phase:
Early Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Rosuvastatin Calcium